 |
인쇄하기
취소
|
Daewoong Pharm seeks bigger market share of Naramig
Daewoong Pharm plans to expand its share of Naramig tablets (naratriptan) as one of the leading items in the local anti-migraine drug market.
Naratriptan is a triptan drug developed by GSK and is used for the treatment of migraine headaches.
Last month, Yoon Jae-seung, vice president of Daewoong Pharm, and Kim Chin-ho, the CEO of GSK, signed a memorandum of understanding to boost business...
Naratriptan is a triptan drug developed by GSK and is used for the treatment of migraine headaches.
Last month, Yoon Jae-seung, vice president of Daewoong Pharm, and Kim Chin-ho, the CEO of GSK, signed a memorandum of understanding to boost business...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.